Association of
+7 (495) 933-7040


EEC and AIPM Discussed the Development of the Single Market of Medicines in EAEU 11.06.2021

June 11, 2021, Moscow – Representatives of the Eurasian Economic Commission (EEC) and the Association of International Pharmaceutical Manufacturers (AIPM) held the working meeting on the development of the single market of medicines in the EAEU.

Five steps to urgently advance COVID-19 vaccine equity 20.05.2021 19 May 2021 – Innovative vaccine manufacturers and biotech companies are at the forefront of the global effort to develop and manufacture COVID-19 vaccines. This massive effort is succeeding. After more than 200 clinical trials and nearly 300 partnerships and collaborations among manufacturers worldwide, production has increased, in just a few months from zero to 2.2 billion COVID-19 vaccine doses by the end of May with an astounding estimate of 11 billion doses by the end of 2021 (Airfinity data here). This will be enough doses to vaccinate the world’s adult population.
Patient-oriented approach of international pharmaceutical industry in Russia 13.05.2021

May 13, 2021, Saint Petersburg — COVID-19 has had a significant impact on the socio-economic development of countries and especially with regards to the healthcare. For more than a year now, the world has been living in completely new conditions, and the pharmaceutical industry has made an important contribution in the efforts to find out optimal solutions to handling the fallout from the health crisis. During the press briefing of the Association of International Pharmaceutical Manufactures (AIPM), traditionally held during the Russian Pharmaceutical Forum in St. Petersburg, heads of the leading international companies and representatives of the patient community shared their vision of the key challenges and lessons learned following the start of pandemic. They also discussed emerging trends in development of regulatory environment, as well as what further steps are needed to successfully achieve the national healthcare goals. Almost each speaker brought attention to the point that current interaction mode demonstrates how successful the healthcare solutions might be if developed through close cooperation between regulators and the industry on regular bases, how significantly grew speed in decision-making across all sectors of the healthcare, while also stressing the need to focus on the patient-centricity when developing all state programs or initiatives. 

STADA readmitted to AIPM 14.12.2020

December 14, 2020, Moscow - The Association of International Pharmaceutical Manufacturers (AIPM) announces an addition to its membership.  Pursuant to a resolution of the General Meeting, the STADA pharmaceutical company has been admitted to AIPM.  

RBC newspaper issued the joint public address of the 11 largest industry associations to the President of the Russian Federation Vladimir Putin on T&T 11.06.2020

It reflects the extreme concern of the professional community about the risk of interruptions in the supply of medicines to the population of the Russian Federation in connection with the expected introduction of the Trace & Track system for medicines as of July 01, 2020. 

Responding to the Challenges of the COVID-19 Pandemic 18.05.2020
  • The changes in the regulation environment and transition to digital interactions, which were aimed at fighting against COVID-19, have proven to be effective. This experience should be broadly exploited in the future to deal with other challenges that the national healthcare system is facing.
AIPM consolidates efforts of international pharmaceutical companies to ensure uninterrupted supplies of medicines and support the Russian healthcare system 10.04.2020

April 9, 2020, Moscow – The international pharmaceutical industry reaffirms its global and regional commitment to attract the industry expertise and know-how needed to accelerate the development of safe and effective new vaccines, diagnostics and treatments to use in the fight against COVID-19 in collaboration with all stakeholders. In context of the COVID-19 pandemic and unprecedented challenges for public healthcare, companies and leading global industry associations – IFPMA (International Federation of Pharmaceutical Manufacturers & Association) and EFPIA (European Federation of Pharmaceutical Industries and Associations), of which AIPM is a member – have voiced their willingness to support public healthcare systems around the world during these difficult times.

Vasily Ignatiev, CEO of R-Pharm, re-elected as the Vice Chairman of the Board of Directors of AIPM 28.02.2020

February 26, 2020, Moscow – The Association of International Pharmaceutical Manufacturers (AIPM) announces that Board of Directors has confirmed the authority of Vasily Ignatiev, CEO of R-Pharm, as Vice Chairman of the AIPM Board of Directors for the second term.

Mrs. Oxana Monge, General Manager of Sanofi Eurasia, Elected the Chair of AIPM Board of Directors 03.02.2020

3 February 2020, Moscow – The Association of International Pharmaceutical Manufacturers (AIPM) announces that according to the Statutes and by the decision of the AIPM Board of Directors Mrs. Oxana Monge, General Manager, Sanofi Eurasia, has been elected the Chair of the Board of Directors at AIPM.

Vladimir Shipkov: we suggest to ensure step-by-step introduction of the track & trace system with full testing at all stages of drug circulation 11.11.2019

Introduction of the Track&Trace system for medicines has been discussed at Izvestiya Multimedia Information Center (MIC).

Opportunities, challenges and key enforcement issues in creation the common markets of medicines in EAEU and EU were discussed on the conference organized by AIPM,EFPIA, DIA in Moscow on October 22, 2019 29.10.2019

Representatives of the EEC and regulatory authorities of EAEU member-states, industry associations and the sector in cooperation with the leading international experts discussed the prospects, key challenges and law enforcement issues in creation of the common market of medicines in the EAEU and EU. 

To Mark Its 25th Anniversary AIPM launches the "On the Way to 80+" Communication Campaign. 23.09.2019

Representatives of the Association of International Pharmaceutical Manufacturers talk about their contribution to achieving key national health indicators: #aipm25to80, #pharma_onthewayto80, #вместеради80плюс, #aipm25

On the Way from 25 to 80+: Impact of Pharmaceutical Industry in Achieving National Healthcare Goals 17.05.2019 Representatives of the international pharmaceutical industry confirmed their commitment to contribute to the implementation the targets set by the government
25th Russian Pharmaceutical Forum will be taking place in St.Petersburg on 14 – 15 May, 2019. AIPM and Russian Pharmaceutical Forum celebrates 25th Anniversaries. 02.04.2019 25th Russian Pharmaceutical Forum will take place in St.Petersburg on 14th – 15th May, 2019.  Don’t miss this unique opportunity to meet with all international and local pharmaceutical market players in Russia to discuss sector challenges and exchange the latest news!
Leading associations of the pharmaceutical industry identified risks to drug provision due to a radical change in T&T concept 18.12.2018 December 18, 2018, Moscow – The pharmaceutical industry professional associations called for maintaining the technical conditions for implementing the project for monitoring the movement of medicines within the framework of the requirements developed earlier in the pilot project. At the same time, the Association of Russian Pharmaceutical Manufacturers, the Association of International Pharmaceutical Manufacturers, the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union, the APF National Association of Pharmaceutical and Medical Products Manufacturers, the Soyuzpharma Association of Pharmaceutical Institutions reaffirmed the principled commitment of their associations to the implementation of a system of labeling and traceability of medicines.
AIPM welcomes new members: Krewel Meuselbach GmbH and Veolia Water Technologies became members of the Association 11.12.2018 December 11, 2018, Moscow – The Association of International Pharmaceutical Manufacturers (AIPM) announces the expansion of its membership. Following the results of the AIPM General Meeting, the German pharmaceutical company Krewel Meuselbach GmbH and French company Veolia Water Technologies were elected as new members of the association. 
Developing Cross-Industry Responsible Self-Regulation: The Federal Antimonopoly Service of the Russian Federation and Professional Associations Have Agreed to Common Approaches to Advertising Legislative Compliance 13.11.2018 On November 7, 2018, the leading professional associations in the pharmaceutical industry and communication services market, in the presence of FAS Russia, signed the “Recommendations on compliance with legislation on advertising of non-prescription medicines” in Moscow. It was developed in close cooperation with FAS Russia.  
Effective Pharmacovigilance system is the Basis of Safety and Wellbeing of Patients 17.10.2018 The first International Conference “PHARMACOVIGILANCE. Challenges and opportunities”, unprecedented in its speakers and content, took place on October 10, 2018 in Moscow. More than 600 experts in the field of drug safety monitoring took part in the Conference. The event was organised by the Federal Service for Surveillance in Healthcare (Roszdravnadzor) and the Association of International Pharmaceutical Manufacturers (AIPM).
Electronic submissions in EAEU & ICH region - current practice & future developments for pharma regulation 19.06.2018

On June 18, 2018 in Moscow the Regulatory Workshop was organized by Eurasian Economic Commission and AIPM & EFPIA with participation (F2F & VC format) of regulatory authorities of EAEU member-states, EU regulators, IT specialists and industry to discuss regulatory aspects, practical implementation issues and road map of eCTD implementation in ICH region & electronic submissions in EAEU region.

International pharmaceutical industry offers a new level of professional dialogue and partnership 23.05.2018

On May 15, 2018 in the frame of Russian Pharmaceutical Forum in St. Petersburg, a press briefing of the Association of International Pharmaceutical Manufacturers (AIPM) was held, entitled “PHARMA 2030: what is needed to develop innovation and attract investment in the pharmaceutical industry in Russia?”.